Kaleido Stock Alpha and Beta Analysis

KLDO -  USA Stock  

USD 5.69  0.03  0.52%

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Kaleido Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Kaleido Biosciences over a specified time horizon. Remember, high Kaleido Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please see Kaleido Biosciences Backtesting, Kaleido Biosciences Valuation, Kaleido Biosciences Correlation, Kaleido Biosciences Hype Analysis, Kaleido Biosciences Volatility, Kaleido Biosciences History and analyze Kaleido Biosciences Performance.

Search Beta 

 
Refresh
Please note that although Kaleido Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Kaleido Biosciences did 0.18  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Kaleido Biosciences stock's relative risk over its benchmark. Kaleido Biosciences has a beta of 0.49  . Let's try to break down what Kaleido's beta means in this case. As returns on the market increase, Kaleido Biosciences returns are expected to increase less than the market. However, during the bear market, the loss on holding Kaleido Biosciences will be expected to be smaller as well.
Kaleido Biosciences Book Value per Share is quite stable at the moment as compared to the past year. The company's current value of Book Value per Share is estimated at 0.66. Tangible Assets Book Value per Share is expected to rise to 1.82 this year, although Enterprise Value over EBIT will most likely fall to (4.11) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Kaleido Biosciences Quarterly Book Value per Share

1.182Share

Kaleido Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Kaleido Biosciences market risk premium is the additional return an investor will receive from holding Kaleido Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Kaleido Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Kaleido Biosciences' performance over market.
α-0.18   β0.49
90 days against DJI

Kaleido Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Kaleido Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Kaleido Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Kaleido Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Kaleido Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kaleido Biosciences shares will generate the highest return on investment. By understating and applying Kaleido Biosciences stock market price indicators, traders can identify Kaleido Biosciences position entry and exit signals to maximize returns.

Kaleido Biosciences Return and Market Media

The median price of Kaleido Biosciences for the period between Tue, Jun 29, 2021 and Mon, Sep 27, 2021 is 6.11 with a coefficient of variation of 12.32. The daily time series for the period is distributed with a sample standard deviation of 0.79, arithmetic mean of 6.4, and mean deviation of 0.68. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
      Timeline 
1
EPS Estimate06/30/2021
2
Acquisition by Prener Anne of 15000 shares of Kaleido Biosci...07/01/2021
3
Filing07/02/2021
4
Kaleido Biosciences Inc gains 5.97 percent for July 16 - Equ...07/16/2021
5
Kaleido Biosciences Inc falls 3.11 percent for August 6 - Eq...08/06/2021
6
Financial Statements08/09/2021
7
EPS Reported08/11/2021
8
Kaleido falls 0.66 percent for August 18 - Equities.com08/18/2021
9
Kaleido falls 0.50 percent to Close at 6.01 on August 25 - E...08/25/2021
10
Kaleido falls 3.54 percent to Close at 5.99 on August 30 - E...08/30/2021
11
Acquisition by Van Hylckama Vlieg Johan of 40000 shares of K...09/02/2021
12
Other09/03/2021
13
Childrens Health Defense Sues the Food and Drug Administrati...09/07/2021
14
Kaleido falls 1.65 percent for September 15 - Equities.com09/15/2021

About Kaleido Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Kaleido Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Kaleido Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Kaleido Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kaleido Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Kaleido Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Kaleido Biosciences. Please utilize our Beneish M Score to check the likelihood of Kaleido Biosciences' management manipulating its earnings.
Upcoming Quarterly Report1st of November 2021
Next Earnings Report2nd of March 2022
Next Fiscal Quarter End30th of September 2021
Next Fiscal Year End2nd of March 2022
Last Quarter Report30th of June 2021
Last Earning Announcement30th of September 2020

Build Portfolio with Kaleido Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Kaleido Biosciences Backtesting, Kaleido Biosciences Valuation, Kaleido Biosciences Correlation, Kaleido Biosciences Hype Analysis, Kaleido Biosciences Volatility, Kaleido Biosciences History and analyze Kaleido Biosciences Performance. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Kaleido Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kaleido Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kaleido Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...